1-4 of 4
Deepa Manwani
Close
Sort by
Journal Articles

Pharmacokinetics, pharmacodynamics, safety, and efficacy of crizanlizumab in patients with sickle cell disease

Clinical Trials & Observations
Julie Kanter, R. Clark Brown, Cynthia Norris, Santosh M. Nair, Abdullah Kutlar, Deepa Manwani, Nirmish Shah, Chiaki Tanaka, Shankaranand Bodla, Gessami Sanchez-Olle, Urs Albers, Darla Liles
Journal: Blood Advances
Blood Adv (2023) 7 (6): 943–952.
https://doi.org/10.1182/bloodadvances.2022008209
Published: 2023
Includes: Multimedia, Supplemental data
Journal Articles

Elucidating parasite and host-cell factors enabling Babesia infection in sickle red cells under hypoxic/hyperoxic conditions

Divya Beri, Manpreet Singh, Marilis Rodriguez, Mihaela Barbu-Stevanovic, Giselle Rasquinha, Avital Mendelson, Xiuli An, Deepa Manwani, Karina Yazdanbakhsh, Cheryl A. Lobo
Journal: Blood Advances
Blood Adv (2023) 7 (4): 649–663.
https://doi.org/10.1182/bloodadvances.2022008159
Published: 2023
Includes: Supplemental data
Journal Articles

GRNDaD: big data and sickle cell disease

Sophie Lanzkron, Deepa Manwani, Payal Desai, Julie Kanter, Jane Little
Journal: Blood Advances
Blood Adv (2022) 6 (3): 1088.
https://doi.org/10.1182/bloodadvances.2021005282
Published: 2022
Includes: Supplemental data
Journal Articles

Clinical predictors of poor outcomes in patients with sickle cell disease and COVID-19 infection

Clinical Trials & Observations
Caterina P. Minniti, Ahmar U. Zaidi, Mehdi Nouraie, Deepa Manwani, Gary D. Crouch, Andrew S. Crouch, Michael U. Callaghan, Sarah Carpenter, Charleen Jacobs, Jin Han, Jena Simon, Jeffrey Glassberg, Victor R. Gordeuk, Elizabeth S. Klings
Journal: Blood Advances
Blood Adv (2021) 5 (1): 207–215.
https://doi.org/10.1182/bloodadvances.2020003456
Published: 2021
Includes: Supplemental data